According to GlobalData’s medical device pipeline database, 17 Upper Extremity Braces and Supports devices are in various stages of development globally. GlobalData’s report Upper Extremity Braces and Supports provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, eight are in active development, while the remaining nine are in an inactive stage of development. There are five products in the early stages of development, and the remaining three are in the late stages of development.

Upper extremity braces and supports are utilized to prevent injuries to or provide support to the joints in the upper limb, including the elbow and wrist joints. One unit refers to one upper extremity brace or support.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Upper Extremity Braces and Supports pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Upper Extremity Braces and Supports devices. Overall, most of these Upper Extremity Braces and Supports pipeline devices are being developed by private entities.

Key players involved in the active development of Upper Extremity Braces and Supports include AIM Laboratory, Columbia University, Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV, Louis Stokes Cleveland VA Medical Center, Manometric, Medical University of South Carolina, Northern Illinois University, Orthoflex, Polytechnic University of Catalonia and Redyns Medical.

For a complete picture of the developmental pipeline for Upper Extremity Braces and Supports devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.